Sitemap

April 21, 2017 Articles

Filter by Available Specialty
  1. A conservative approach to compassionate care for ESRD patients
  2. AASM: Delaying school start time benefits student health
  3. Abstracts at NKF meeting look at benefits of integrated care
  4. AMA, collaborators provide ‘bold, innovative’ EHR training
  5. Arthritis of the Elbow, Wrist and Hand
  6. ASCO updates treatment guideline for potentially curable pancreatic cancer
  7. B+L contact lens recycling program gains momentum
  8. Beaver-Visitec acquires Malosa Medical
  9. Biosimilars to rituximab, etanercept recommended for approval in Europe
  10. BLOG: Value of office-based ERG and VEP
  11. Broad-spectrum testing detects pathogens in 34% of patients with CAP of unknown cause
  12. CDI recurrence linked to higher mortality, health care costs
  13. CHECKMATE: Experienced HCC patients respond well to Opdivo
  14. Colonoscopy prevented more than 50,000 deaths from CRC in the US over 3 years
  15. Concussion increases risk for cognitive, psychiatric impairments in hockey players
  16. Creating a wearable artificial kidney: A difficult but necessary goal
  17. DAAs may impact inflammatory markers in cirrhosis, HCC surveillance
  18. DoD awards MeMed $9.2 million for platform that distinguishes between bacterial, viral infections
  19. Eight noteworthy FDA actions
  20. Eight weeks of glecaprevir/pibrentasvir effective in genotype 3 HCV
  21. EVAR using percutaneous femoral access benefits patients with obesity
  22. FDA approves biosimilar for infliximab
  23. Fibrosis can serve as surrogate endpoint for clinical trials of NASH
  24. FMT improved cognitive function in hepatic encephalopathy
  25. Football training program linked with reduced concussion rates among high school players
  26. Harry S. Brown, MD, FACS, founder of SEE International, dies
  27. Health care expenditure burden high in adrenal insufficiency
  28. High-dose vitamin D does not affect muscle strength, balance in postmenopausal women
  29. Hospital-based primary care settings more likely to provide unnecessary services
  30. Idiopathic hyperprolactinemia increases anterior pituitary hormone deficiency risk
  31. Inhaled corticosteroids may benefit patients with sickle cell disease
  32. Kinase Inhibition in Rheumatology: Cutting Edge of the Brave New World of Therapeutics
  33. Longitudinal study launched to help determine transition from health to disease
  34. Maternal type 1 diabetes influences adiponectin, leptin levels in adolescent offspring
  35. Moxidectin shows promise as alternative treatment for S. stercoralis
  36. NASS opens 30-day comment period for new coverage recommendations
  37. Norfloxacin bested placebo in reducing mortality in HCV cirrhosis
  38. One-third of UK adolescents with HCV developed serious liver disease
  39. Patients report adalimumab for uveitis improves quality of life
  40. Patients treated with tocilizumab for RA showed sustained improvements through second year
  41. Patients with MI near route of marathon face higher mortality risk
  42. Repeated anti-VEGF injections reduces outflow in AMD patients
  43. RESTORE: Resveratrol may not help walking performance in patients with PAD
  44. Revision TKA for flexion instability yielded lower functional improvements
  45. Severe hot flashes increase risk for depression
  46. Sex steroid concentrations linked with lean mass changes in men
  47. Significant gaps in kidney disease care worldwide
  48. Teaching happiness benefits men newly diagnosed with HIV
  49. Tocilizumab linked with highest risk for neutropenia in comparison study that included abatacept, infliximab
  50. Treatments for androgenetic alopecia varies in effectiveness between men, women
  51. Valeant announces pricing for Siliq for plaque psoriasis
  52. Vitamin D supplements fail to prevent CVD
  53. What Rheumatologists Need to Know About Janus Kinase Inhibitors
  54. WHO launches first ever global hepatitis report
  55. Women considering double mastectomies satisfied with surgery choices
  56. Youth infected with HIV more susceptible to adverse outcomes in adolescence, young adulthood
  57. Zepatier yields high SVR12 in real-world VA cohort